Secure eHealth Health Information Exchange Integration Shown at HIMSS 2011 Interoperability Showcase as Part of GSI Health Tech

^{Published on 2011-02-22 05:40:46 - Market Wire}
 

Secure eHealth Health Information Exchange Integration Shown at HIMSS 2011 Interoperability... -- FORT WORTH, Texas, Feb. 22, 2011 /PRNewswire/ --

FORT WORTH, Texas, Feb. 22, 2011 /PRNewswire/ -- Wound Management Technologies, Inc., (WNDM) announced today that Secure eHealth's secure messaging and data delivery solution, CifraHC will be included as part of GSI Health's demonstration of a system capable of securely transporting clinical documentation in a fully integrated, multiple partner solution during the 2011 HIMSS Interoperability Showcase February 21– February 24 in Orlando, Florida.

Robert Tapales, Secure eHealth President explained, "Traditionally, in order for a provider to participate in a health information exchange it required that the provider have a compatible EHR (Electronic Health Record) system.  The GSI Health integrated solution which incorporates the CifraHC secure communications platform from Secure eHealth allows providers both with and without EHRs secure and efficient access to clinical data from within an HIE network."

The CifraHC, secure messaging and encrypted transport solution serves to securely store, notify and provide access to sensitive clinical data through its integration with GSI Health's HISP (Health Information Service Provider).

The process can be broken down into a few simple steps:

1. A healthcare record is generated by essentially any system and is placed in the CifraHC Vault
2. Intended recipients that are part of the HIE are notified using direct push notifications to smart devices, emails or SMS
3. Users access the record from virtually anywhere through their secure CifraHC Viewer

The HIMSS conference is considered the largest gathering of healthcare IT in the nation. The conference regularly draws between 25,000 and 30,000 professionals from around the world interested in the latest industry advances. For additional information on how Secure eHealth is part of the Interoperability Showcase demonstration please visit [ www.secureehealth.com ]

About Secure eHealth, LLC

Secure eHealth, LLC is a wholly owned subsidiary of Wound Management Technologies, Inc. (OTCBB: WNDM) and is a secure messaging and data delivery solutions provider for the public/private and government healthcare sector. Secure eHealth's mission is to encourage collaborative healthcare delivery by creating platforms where healthcare practitioners, ancillary providers, medical facilities and patients can freely share information safely and securely. For more information about Secure eHealth, LLC go to [ www.secureehealth.com ].

About Wound Management Technologies, Inc.

Wound Management Technologies, Inc. is an emerging commercial stage company with its primary products in the $5B worldwide advanced wound care market. It is estimated that aging populations and the increase of the number of patients diagnosed with diabetes will fuel additional rapid growth of this market. Wound Management's primary focus is the distribution of its unique, patented collagen product, CellerateRX®, which is FDA cleared and reimbursable under Medicare Part B. It has proved to be both clinically effective and cost effective with broad uses over a wide spectrum of wounds. In 2010 the company focused on developing and executing a sales strategy for both the US and international market and the company believes it is well positioned to be cash flow positive and profitable within the next 12-24 months. Wound Management has other advanced biotech products in development including a patented resorbable bone wax line that is in late stages of development, as well as a subsidiary focused on technology for secure healthcare data collaboration and storage.  More information can be found on the company's web sites: [ http://www.wmgtech.com ] and [ http://www.celleraterx.com ].

Safe Harbor Statement:

The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development and any other statements not constituting historical facts are "forward-looking statements," within the meaning of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks, contingencies and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks, contingencies and uncertainties detailed in the Company's SEC filings, which could cause the company's actual operating results, performance or business plans or prospects to differ materially from those expressed in, or implied by these statements. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.

For Wound Management Technologies Shareholder Information please call (917) 974-9872 or visit [ http://www.wmgtech.com ]

SOURCE Wound Management Technologies, Inc.

RELATED LINKS
[ http://www.wmgtech.com ]